A5040361012- Prostate Cancer Treatment and Research
- Peptidase Inhibition and Analysis
- Hormonal and reproductive studies
- Radiopharmaceutical Chemistry and Applications
- Cancer, Lipids, and Metabolism
Institut Génétique Nantes Atlantique
2024
Institut de Cancérologie de l'Ouest
2023
Background: In hormone-sensitive oligorecurrent prostate cancer (PC), the literature showed [68Ga]Ga-PSMA (PSMA) and [18F]F-choline (FCH) PET/CT can successfully guide metastasis-directed therapies (MDT). This observational retrospective study aimed to explore, in routine use, impact of FCH or PSMA guiding MDT for oligometastatic PC at different recurrences. Methods: 2017–2020, patients initially treated with radical prostatectomy but, biochemical recurrence (with PSA ≤ 2 ng/mL), diagnosed...
Abstract Tumor-associated macrophages are targets of interest in triple-negative breast cancer (TNBC). The translocator protein 18 kDa (TSPO) is a sensitive marker for and holds potential relevance TNBC stratification. This pilot prospective study (EITHICS, NCT04320030) aimed to assess the TSPO PET/CT imaging using F-DPA-714 primary TNBC, compared with immunohistochemistry, autoradiography, polymorphism. Patients Methods Thirteen patients were included. They underwent genotyping (HAB, MAB,...